Category: Editorial

August 31, 2022

People around the world, scientists, and policymakers have undoubtedly learned numerous lessons from the COVID-19 pandemic. This healthcare crisis has shown the importance of being prepared to face a new epidemic or pandemic, as well as the need to develop […]

July 22, 2022

While the COVID-19 pandemic wreaked havoc and forced scientists and policymakers to create or search for vaccines and treatments, common disorders continued to affect millions of human lives. The pandemic made it harder for people suffering from chronic conditions to […]

June 22, 2022

At the beginning of the COVID-19 pandemic, people around the world were comparing the new disease with the flu, also known as influenza. However, while both diseases cause respiratory symptoms, it soon became very clear that there are some important […]

May 16, 2022

Nothing could make the benefits of vaccination easier to understand than the recent COVID-19 pandemic and its catastrophic effects. However, when it comes to vaccinating children and teenagers, many people around the world showed reluctance due to the potential negative […]

April 25, 2022

At the same time that the implications of the global pandemic have created difficulties for many, they have also sparked an opportunity for growth and change.  One key area that has continued to evolve even as we return to a […]

April 8, 2022

More than two years have now passed since the beginning of the COVID-19 pandemic—an epidemic that turned into the most serious healthcare crisis in modern history. According to Johns Hopkins University, 6.16 million people have lost their lives to the […]

March 21, 2022

The recent healthcare crisis differed from earlier emergencies because it has spread to impact most industries and multiple financial systems around the world. As the COVID-19 pandemic continued for more than two years, countries around the world struggled to keep […]

February 22, 2022

As the Omicron variant of the virus that caused the current pandemic spreads and mutates, people are left hoping this will be the end of the healthcare crisis. Unlike previous variants, Omicron seems to be more infectious but less severe. […]

December 29, 2021

The COVID-19 pandemic has demonstrated that it is essential for biopharmaceutical organizations to act quickly and become flexible in production.  Experts, such as the CHEManager International team, view four factors as unsolved challenges. They claim that the first challenge is […]

November 30, 2021

Almost two years have passed since the beginning of the COVID-19 pandemic that reshaped the world as we knew it. The virus responsible for the disease not only infected millions of people around the world, but also changed the way […]

October 29, 2021

As the COVID-19 pandemic continues to spread across the globe, many people are worried that the current vaccination may not be sufficient to curb the spread of the virus. While the successful development of effective vaccines has been one of […]

September 30, 2021

The COVID-19 pandemic has reshaped industries—especially healthcare and biopharma.  While vaccines provided governments and people in the US and abroad with a new way of fighting the virus, more help is needed. As a significant percentage of the population remains […]

August 30, 2021

The ongoing COVID-19 pandemic has sparked an unprecedented crisis for governments, healthcare providers, and industries across the world. Biopharmaceutical companies were especially affected, as they were left struggling to develop solutions that will ultimately help diagnose and treat those suffering […]

July 30, 2021

The Delta variant of the coronavirus has become the dominant strain around the world, bringing with it an increase in deaths in the US and many other countries. While the victims are almost exclusively unvaccinated, the new surge seems to […]

June 30, 2021

In 1982, the U.S. approved human insulin—the first ever recombinant biopharmaceutical drug. Since then, biopharma development has proceeded at an exponential pace, with new innovations redefining, over and over again, the possibilities of medicine.  Going forward, biopharma will demand more […]

May 28, 2021

With COVID-19 vaccines becoming more widely available around the world, and countries everywhere easing restrictions, a return to normal is now on everyone’s mind. While many activities are still recovering and regulations remain an important part of our daily lives, […]

April 30, 2021

Biopharmaceuticals are among the most complex and elegant realizations of modern science. But this complexity also comes at great cost. More exactly, biotech-manufacturing facilities need between $200 and $500 million to be built and this process could last up to […]